Lipopolysaccharides (LPS) that lack acyloxyacyl groups can antagonize responses to LPS in human cells. Although the site and mechanism of inhibition are not known, it has been proposed that these inhibitory molecules compete with LPS for a common cellular target such as a cell-surface binding receptor. In the present study, we used an in vitro model system to test this hypothesis and to evaluate the role of CD14 in cellular responses to LPS. Cells of the THP-1 human monocytemacrophage cell line were exposed to 1,25 dihydroxyvitamin D3 to induce adherence to plastic and expression of CD14, a binding receptor for LPS complexed with LPS-binding protein (LBP). The uptake of picograms of [3H]LPS (agonist) and enzymatically deacylated LPS [3H]dLPS (antagonist) was measured by exposing the cells to the radiolabeled ligands for short incubation periods. The amounts of cell-associated LPS and dLPS were then correlated with cellular responses by measuring the induction of nuclear NF-KB binding activity and the production of cell-assodated interleukin (IL)-IB. We found that similar amounts of [3H]LPS or [3H]dLPS were taken up by the cells. The rate of cellular accumulation of the ligands was greatly enhanced by LBP and blocked by a monoclonal antibody to CD14 (mAb 60b), yet no cellular responses were induced by dLPS or dLPS-LBP complexes. In contrast, LPS stimulated marked increases of NF-rB binding activity and Ibl~. These responses were enhanced by LBP and inhibited by mAb 60b. dLPS and its synthetic lipid A counterpart, LA-14-PP (also known as lipid Ia, lipid IVa, or compound 406) strongly inhibited LPS-induced NF-KB and IL1B, yet neither antagonist inhibited the uptake of LPS via CD14. dLPS did not inhibit NF-KB responses to tumor necrosis factor (TNF)c~ or phorbol ester. Our results indicate that (a) both stimulatory and nonstimulatory ligands can bind to CD14 in the presence of LBP; (b) the mechanism of inhibition by dLPS is LPS-specific, yet does not involve blockade of LPS binding to CD14; and (c) in keeping with previous results of others, large concentrations of LPS can stimulate the cells in the absence of detectable binding to CD14. The findings indicate that the site of dLPS inhibition is distal to CD14 binding in the LPS signal pathway in THP-1 cells, and suggest that molecules other than CD14 are important in LPS signaling. nimals have sensitive mechanisms for recognizing and responding to gram-negative bacterial LPS (also called endotoxin). Several cellular mechanisms for binding LPS have been described (1-8) and recent evidence suggests that the uptake of LPS by cells of monocytic origin (macrophages, monocytes) or neutrophils is linked to LPS recognition and cellular responses. However, the relationships between LPSbinding proteins in the cell membrane and signaling pathways are not understood.
freshly drawn whole blood ex vivo (8, 12) , and CD14-transfected 70Z/3 cells (13) support the contention that the LBP/CD14-dependent pathway is closely linked to initiation of cellular responses. Two models have been proposed to explain how this pathway might function in LPS signaling (1, 2) . In the first modal, LPS binding to CD14 directly stimulates the cell, whereas in the second, the CD14-LPS interaction facilitates the subsequent interaction of LPS with another signaling molecule. A direct signaling role for CD14 is suggested by reports that certain anti-CD14 mAbs can mimic some of the effects of LPS in human monocytes (14, 15) . The second model is supported by the observation that increasing concentrations of LPS can overcome the ability of blockade or depletion of CD14 to inhibit TNFol production (8) .
The study of lipid A analogs that can function as LPS antagonists should provide useful information about the LPS signal pathway. One such analog is produced by the leukocyte enzyme, acyloxyacyl hydrolase (AOAH), which selectively removes secondary acyl chains from the lipid A region of LPS (16, 17) . Several laboratories have reported that enzymatically deacylated LPS (dLPS) (18) (19) (20) (21) and its lipid A counterpart (known variously as synthetic analogs LA-14-PP or 406, or biosynthetic precursors Ia or IVa) (21) (22) (23) (24) (25) (26) can inhibit the ability of LPS or lipid A to stimulate human cells. Although most investigators have assumed that these inhibitors compete with LPS for a common cellular target molecule, the site and mechanism of inhibition have not been determined.
In this paper we describe the uptake of picograms of biosynthetically radiolabeled Escherichia coli LPS and dLPS by the human monocyte-macrophage cell line, THP-1. (The term "uptake" is used here to refer to the association of LPS with the cell and is a measure of both membrane-bound and internalized LPS.) The uptake of both of these ligands was enhanced in the presence of LBP and blocked by a mAb to CD14. LBP also enhanced the ability of LPS to induce NF-KB and Iblf3 responses by these cells, but neither dLPS nor dLPS-LBP triggered these responses. Remarkably, dLPS-LBP and LA-14-PP-LBP inhibited responses to LPS-LBP without diminishing LPS uptake by the cells. These observations indicate that CD14 can participate in the cellular uptake of both stimulatory (LPS) and nonstimulatory (dLPS) ligands. Moreover, the mechanism of inhibition by dLPS does not involve inhibition of LPS binding to CD14. Our data suggest that dLPS may block the binding of LPS to a low-abundance fignaling molecule, or that the uptake of dLPS may initiate a negative signal that counteracts or blocks the LPS signal to the cell.
Materials and Methods
Cell Cultur~ THIXl cells were obtained from Dr. Dario C. AItieri (The Scripps Research Institute, LaJolla, CA) and were grown in RPMI-1640 with 7% fetal bovine serum (heat-inactivated at 56~ for 30 rain) (Hyclone Laboratories Inc., Logan, UT), 2 mM L-glutamine, 50 U/ml penicillin G, and 50/~g/ml streptomycin in a 5% COz atmosphere at 37~ To minimize cell variability, the cells were revived from frozen stock every 2-3 too. To induce adherence to plastic and expression of CD14, cukures were grown in 6-well plates (Costar, Cambridge, MA) in the presence of 0.1/~M 1,25-dihydroxy vitamin D3 (Biomol Res. Laboratories, Inc., Plymouth Meeting, PA). After 72 h, cultures were fed by adding 0.5 vol of medium containing vitamin D3 and incubated for another 24 h.
Antibodies and Reagents. Anti-CD14 mAbs, 60b (IgG1) (27) and 26ic (IgG2b) (28) , were kindly provided by Robert F. Todd (University of Michigan, Ann Arbor). Anti-CD18 mAb, 60.3 (IgG2a) (29) , was kindly provided by John M. Harlan (University of Washington, Seattle). Antibodies in ascites fluid were titrated either by FACS | analysis (Becton Dickinson & Co., Mountain View, CA) of binding to THP-1 cells, or by their ability to block LPS uptake (mAb 60b). They were used at 1:500 dilution in the experiments reported here. Nonimmune control antibody used for FACS* analysis (Becton Dickinson & Co.) was a mixture of 2 #g/ml each of routine IgG1, 2a, 2b, and 3 isotypes (Coulter Immunology, Hialeah, FL), and FITC-labeled F(ab')2 fragments of goat anti-mouse IgG (H + L) were from Tago, Inc. (Burlingame, CA). LBP, purified from rabbit acute phase serum, was generously provided by Peter S. Tobias (Scripps Clinic and Research Foundation, La Jolla, CA). Optimal amounts of LBP were determined empirically by measuring LPS uptake using each lot of LBP. Tissue culture-tested, endotoxin-tested (0.005 ng endotoxin/mg) BSA was obtained from Sigma Chemical Co. (St. Louis, MO). Double-stranded poly(dI-dC) was obtained from Pharmacia Fine Chemicals (Piscataway, NJ). Strict pyrogen-free conditions were maintained by using sterile disposable plasticware and pipette tips, and pyrogen-free distilled water (Baxter Healthcare Corp., Deerfield, IL).
LPS and Lipid A Preparations. E. coli LCD25, a K12 derivative with Ra or Rb LPS core structure, was biosynthetically radiolabeled with [3H]acetate as described (30) . Its sp act was 4,200 3H dpm/ng, and essentially all of the radioactivity was in the fatty acyl chains. The radiohbeled LPS was deacylated using AOAH (19) . Sp act of the dLPS preparations used were 2,885 and 3,020 dpm/ng. Both deacyhted and mock-treated LPS were suspended (100/zg/ml) in 0.9% NaC1 with 5 rag/m1 BSA and stored at -70~ Nonradioactive dLPS was produced from E. coli J5 LPS by using trace amounts of [3H] LPS to follow the extent of deacylation. Samples containing deacylation reaction components without LPS ("mock dLPS') were used as controls. Synthetic lipid LA-14-PP from ICN Biomedicals, Inc. (Cleveland, OH), was suspended in PBS, sonicated, and stored (0.5 mg/ml) at -70~ Before use, an aliquot of each LPS or LA-14-PP preparation was diluted to 2/zg/ml in RPMI-1640 containing 0.5 mg/ml BSA and sonicated for 1 s on low power with a sonifier with a small steel probe (model 450; Branson Ultrasonics Corp., Danbury, CT), and the radioactivity in the sample was counted. LPS-LBP complexes were prepared by mixing aliquots of sonicated LPS with LBP immediately before use (typically a 10-fold excess of LBP by weight was used for LPS and dLPS, and a 30-fold excess was used for LA-14-PP), incubated 10 min at 37~ diluted with RPMI/BSA to the working concentration, and kept at room temperature until used. Tritium counting was performed in a liquid scintillation counter (Tricarb 4000 Minaxi; Packard, Downers Grove, IL) with external standardization and quench correction.
Cell Stimulation. 96-h cultures of vitamin D3-treated THP-1 cells were prepared in 6-well plates as described above. Nonadherent cells were removed by washing with RPMI, and incubations were performed in the absence of serum using 1 ml of RPMI containing penicillin, streptomycin, glutamine, and 0.5 mg/ml BSA. Additions of LPS and other reagents were made in 10-100/zl volumes. After incubation, cells were washed at room temperature once with 2 ml of R.PMI/BSA medium followed by two washes with 2 ml of PBS. Cells were then placed on ice until addition of buffer A (see below). Assays for uptake, NF-gB, Iblfl, and protein were performed in each experimental sample as described bdow. Each data point represents the mean value of duplicate wells, and error bars are shown in the figures when the range of the duplicates exceeded the size of the markers. Each observation was repeated at least three times with similar results.
Nuclear Extracts and Cell Lysates. The nuclear extract for NF-~B assay and the ceil lysate for assay of ceil-associated IL-lfl and uptake of radiolabeled LPS were prepared from the same experimental sample by a micro-extraction protocol modified from previous methods 01). Adherent THP-1 ceils (typically 10 ~ ceils/well) were lysed by adding I ml/well of cold buffer A (10 mM Hepes pH 7.9, 1.5 mM MgClz, 10 mM KC1, 0.5 ram dithiothreitol [DTT], 0.5 mM PMSF, and 0.1% (wt/vol) NP-40; PMSF and DTT were added freshly before use). The cell lysate was mixed in an osdlhting ice bath for 5-10 rain and transferred to a microcentrifuge tube. Nuclei were pelleted by centrifugation at 750 g for 5 min at 4~ and an aliquot (typically 0.5 nil) of supernatant was removed for scintillation counting (LPS uptake). Another aliquot was stored at -70~ for IL-lfl assay and the residual supematant was aspirated. The nuclear pellet was vortexed in 15 #1 of buffer C and allowed to stand in ice for 30 n'fin, vortexing at 10-rain intervals~ Buffer C consisted of 20 mM Hepes, pH 7.9, 25% glycerol (vol/vol), 420 mM NaC1, 1.5 mM MgC12, 0.2 mM EDTA, 0.5 mM DTT, and 0.5 mM PMSF. Nuclear extracts were centrifuged at 12,000 g for 10 rain. Each supernatant was removed, mixed with 15 ~1 of buffer D (10 raM Tris ( (21) NF-JcB Assay. Nuclear NF-gB was measured by electrophoretic mobility shift assay (EMSA) by modification of a previous method (32). 10 #1 nuclear extract (typically 4-5/~g protein) were mixed with 5 #1 of a reaction mixture that contained, in 15 #1 final volume, 10 mM Tris(C1), pH 7.5, 50 mM NaC1, I mM DTT, 1 mM EDTA, 5% glycerol, I rag/m1BSA, and 0.1 rag/m1 double-stranded poly(dIdC). After standing on ice 15 rain, 5 #1 of 32P-labeled oligonucleotide (typically 0.2 ng and 50,000 Cerenkov ~m) was added and allowed to stand at room temperature for 20 rain. 2 #1 of 0.1% bromphenol blue was added, and 10 gl of the mixture was loaded onto a 4% polyacrylamide mini-gel (7 cmx 8 era x 1 ram) that had been prerun for 30 re_in. Electrophoresis was for I h at 72 V in running buffer (6.7 mM Tris(Cl) pH 7.5, 3.3 mM sodium acetate and 1.0 mM EDTA). The gel was dried onto paper under vacuum at 80~ for 1 h and visualized by exposure to Kodak X-OMAT AK film (Eastman Kodak Co., Rochester, NY). Retarded bands were cut from the dried gel and Cerenkov cpm were measured by counting in distilled water on an open tritium channel. "Relative NF-gB" refers to the increase in cpm/#g nuclear extract protein above the unstimulated control (e.g., relative NF-gB = 2 indicates a value that is twofold higher than the control). The NF-KB oligonucleotide,
was prepared from synthetic oligonucleotides as a double-stranded 31 mer with 26 bp corresponding to the wild-type murine ~ L chain enhancer sequence (33) . 32p labeling was performed with ot-[3zP]dCTP or dATP using Khnow fragment. The labeled oligonudeotide was purified by successive passes over two Sephadex G-50 spin columns (Pharmada Fine Chemicals).
ILl, Assay. Ceil-associated IDlfl was measured by ELISA using the high-sensitivity IL-lfl kit from Cistron Biotechnology (Pine Brook, NJ). 100 ~1 of postnuclear supernatant was used undiluted or diluted in buffer A. 
Results

Vitamin D3 Induces CD14 Expression and Adherence to Plas~
THP-1, a human leukemia cell line of the monocytemacrophage lineage (34) , was used as a modal system for the present study. Although untreated THP-1 ceils are not adherent and express little or no cell-surface CD14, exposure to 1,25-dihy&oxyvitamin D3-induced adherence to plastic and expression of high levels of cell-surface CD14 (35) ( macrophage-like morphologic appearance (i.e., spreading) in many adherent cells. Fig. 2 A. Unstimulated THP-1 cells expressed low levels of NF-xB (lane 1), and a 1-h incubation with LPS-LBP stimulated a marked increased in NF-xB above control levels (lanes 4 and 5). By contrast, dLPS-LBP did not stimulate NF-xB (lanes 2 and 3). As anticipated, dLPS was also an effective inhibitor of the NF-xB response to LPS (lane 6). This antagonistic effect appeared to be specific for LPS since dLPS did not inhibit the NF-xB response to TNFo~ (lanes 7 and 8) or to phorbol ester (lanes 9 and 10). Serial dilutions of a nuclear extract from LPS-stimulated cells showed good proportionality with Cerenkov cpm, and the ability of unlabeled oligonucleotide to block binding of the labeled oligonudeotide showed specificity (Fig. 2 , B and C).
LPS Uptake
To obtain an independent assessment of cell responses, we measured the accumulation of II.-1B in the same experimental samples used for LPS uptake and NF-xB assay. The 1-h time points used in this study were too early to measure Ibl release into the culture medium, but an early response could 
( B --i ) LPS-LBP; and (O---O) LPS-LBP + 60b. (D) Uptake of LPS without LBP. (ig--I) LPS; (O) LPS + 60b; and (..-.) Nonspedfic binding to plastic in wells with cells removed. (E) NF-xB response. (B---i) LPS; and (O---O) LPS + 60b. (F) ID1B response. (i---i) LPS; and (O---O) LPS + 60b.
be measured in cell lysates. Although at I h the IL-1B levels induced by LPS were low (100-500 pg/106 cells compared with 25-35 pg/106 cells in unstimulated controls) and varied in separate experiments, the measurements were internally consistent within each experiment. Fig. 3, A and D, LBP increased the uptake of LPS by the cells. NF-gB binding activity was increased by LBP throughout the dose range from 0.1 to 10 ng/ml LPS (Fig. 3, B and E) , and an Ibl/3 response was observed only in the presence of LBP (Fig. 3, C and F) .
LBP Augments the Uptake of LPS and Increases LPS-induced NF-KB and II.,I~ Responses. As shown in
Anti-CD14 mAb 60b Blocks Uptake of LPS but Does Not
Completely Prevent Cell Responses. Also shown in Fig. 3, A and D is the impact ofmAb 60b on LPS uptake. 60b blocked all detectable uptake of LPS, whether or not it was complexed with LBP. By contrast, Table 1 shows that uptake was not inhibited by mAb 26ic, previously reported to be a nonblocking antibody to CD14 (8), or by anti-CD18 mAb 60.3. Virtually all of the residual uptake observed after blocking with 60b could be accounted for by nonspecific adherence of LPS to plastic (Table I and Fig. 3, A and D) . In control experiments, 6-well plates were either incubated with complete medium without cells for 96 h, or adherent cells were removed from the wells by vigorous washing.
[3H]LPS-LBP was then added to the wells, the plates were incubated for 1 h at 37~ and residual 3H was measured after washing the wells and adding detergent lysis buffer as described in Materials and Methods. In wells that had been incubated without cells, the average binding was 0.13% + 0.05% SD (n = 3) of the added [3H]LPS. [3H]LPS binding was only slightly higher (0.28% + 0.06% SD, n = 6) when cells had been removed from the plates by washing. * Nonspecific binding to plastic: cells were removed from wells by washing before incubation with labeled compounds as described above. Uptake in dpm from both labeled compounds was ~ equal to the sum of the uptake of the individual compounds. Conversion to pg/106 cells is based on the average specific radioactivity of the two compounds.
This was reduced to 0.35% + 0.14% (n = 8) after blocking with mAb 60b.
As shown in Fig. 3 , B and E, mAb 60b greatly reduced cellular responses to LPS. The NF-xB response was suppressed by 60b at low LPS concentrations (0.1-1 ng/ml), but this inhibition was partially overcome at 3 and 10 ng/ml, mAb 60b also suppressed the Iblfl response (Fig. 3 C) .
dLPS Uptake Is A ~o Enhanced by LBP and Blocked by mA b 60It Fig. 4 shows dose-response curves for [3H]dLPS and
[SH]LPS uptake, in the presence and absence of a 10-fold excess of LBP. LBP greatly enhanced the uptake of both compounds. Optimal amounts of each batch of purified LBP were determined empirically. It was typical for a 5-to 10-fold excess (by weight) of LBP to produce maximal uptake when preincubated in concentrated solution with LPS or dLPS (see Materials and Methods). Using LPS-LBP or dLPS.-LBP complexes preformed at a ratio of 1:10, LBP increased LPS uptake 5.3 fold (_+ 2.6 SD, n = 22) and dLPS uptake 4.2 fold (__ 1.2 SD, n = 6). Fig. 4 also shows that, as for LPS (A), the uptake of dLPS (B) was inhibited by 60b, whether or not the dLPS was complexed with LBP.
The time course for uptake of [3H]dLPS-LBP was nearly identical to that of [3H]LPS-LBP (Fig. 5 A) . by mAb 60b, consistent with uptake via CD14, this observation indicates that engaging CD14 with an LBP-complexed ligand does not necessarily trigger these cell responses.
LPS Induces Nuclear NF-~cB Binding Activity and Cell-associated
dLPS and LA-14-PP Inhibit Responses to LPS without Inhibiting LPS Uptake
To characterize the antagonistic effects of LPS in terms of both [SH]LPS uptake and cellular response, we looked at the interaction of unlabeled dLPS and [SH]LPS ligands that were each prebound to optimal amounts of LBP before they were added to the cells, dLPS-LBP was added in varying amounts to three concentrations of [SH]LPS-LBP. As shown in Fig. 6 , dLPS inhibited NF-xB responses without inhibiting LPS uptake. In experiments not shown, when dLPS-LBP and LPS-LBP were added to cells in equal concentrations, NF-KB levels were inhibited by 66 + 6% SD (n --9) compared to control levels obtained with LPS-LBP alone, yet LPS uptake was not inhibited. The uptake of [SH]LPS ....... 9 ............................ that occurred in the presence of dLPS was also inhihitable by mAb 60b (Table 1 , and data not shown). In experiments not shown, when [3H]LPS and dLPS were not prebound to LBP but were added directly to cells in incubation medium without LBP or with limiting concentrations of LBP, LPS uptake was inhibited to a variable extent (<50% inhibition). This inhibition was largely overcome as the LBP concentration was increased. NF-KB and 11.-1/3 responses were dramatically inhibited by dLPS in the presence or absence of LBP.
To eliminate the possibility that inhibition by dLPS is due to a biological contaminant in the dIPS preparation, similar experiments were performed using LA-14-PP. LA-14-PP is a chemically defined, synthetic analog of lipid A which is structurally equivalent to the lipid A moiety of dLPS. As shown in Fig. 7 (Table 1) were done to exclude the possibility that any characteristics of dLPS inhibition are due to unanticipated structural differences between the unlabeled E. coli J5 dLPS and the E. coli K12 [3H]LPS. As expected, the uptake of each of the labeled ligands was additive, cellular responses were inhibited, and mAb 60b blocked the uptake of both ligands. Control experiments (not shown), in which dLPS was substituted with "mock dLPS" (see Materials and Methods), confirmed that the presence of residual AOAH in the dLPS preparations did not inhibit the ability of LPS to stimulate a cellular response.
Inhibition by dIPS Is Not a Result of LPS Sequestration.
Since LPS can form aggregates in solution (36, 37) , we addressed the possibility that dLPS might sequester LPS binding site(s) that are important for inducing cell responses. We incubated THP-1 cells with varying amounts of dLPS-LBP (0-1 ng/ml) for 1 h, washed the cells, and added 3 ng/ml of [3H]LPS-LBP. As shown in Fig. 8 , preincubation with as little as 0.3 ng/ml dLPS for I h inhibited the NF-~B response to 3 ng/ml LPS by 50%, yet LPS uptake was not inhibited. In experiments not shown, NF-KB responses to submaximal stimulatory amounts of TNFc~ and phorbol ester were not inhibited by dLPS preincubation.
Discussion
Two general models have been put forward to account for the role of CD14 in cellular responses to LPS (1, 2) . The first model proposes that when LPS or LPS-LBP binds CD14, the LPS signal is directly transduced to the cell. In keeping with this model, mAbs to CD14 can trigger a number of responses in monocytes and nentrophils, including ligand interualization, transient oxidative burst, Ibl production (14, 38) , homotypic adhesion (15) , and calcium fluxes (38) . CD14 itself need not be the signal transducer, however, since the signaling molecule might associate with CD14 after initial ligand binding (like the interaction of gp130 with IL-6R) (39), or may be part of a molecular complex with CD14. Close association of CD14 with a protein kinase (40) , for example, might account for the finding that protein tyrosine phosphorylation is induced as an early response to LPS in murine macrophages (41) . In the second model, CD14 is not so directly involved in signaling. Rather, it binds LPS on the cell membrane, where the LPS can interact (possibly by transfer within the membrane or cell) with the actual signaling molecule(s) (1) . This model was proposed to account for the observation that high LPS concentrations overcome the inhibitory effect of blockade or depletion of CD14 on LPS-stimulated TNFc~ production (2, 8) .
We found that the binding of both LPS and dLPS to THP-1 cells was augmented by LBP and inhibited by anti-CD14 mAb 60b, indicating that both ligands were interacting with LBP and CD14, yet only LPS induced NF-gB and ILI~ responses. The ability of LPS and dLPS to associate with the cells in the absence of LBP was also inhibited by mAb 60b, suggesting that both ligands may bind directly to CD14, but only LPS elicited cell responses. CD14 may therefore bind both stimulatory (LPS) and nonstimulatory (diPS) ligands in THP-1 ceils, suggesting that engagement of CD14 is insufficient to produce signals resulting in NF-gB binding activity and IL-1t3 production.
Another remarkable finding, that dLPS and LA-14-PP blocked responses to LPS without inhibiting LPS uptake via CD14, seems most consistent with the second model. The site of apparent competition between LPS and dips occurs after the interaction of LPS with CD14 and might therefore involve binding to a low abundance molecule, the putative signal transducer. A different mechanism for dLPS inhibition of responses to LPS cannot be excluded, however. Since dLPS-LBP is able to inhibit responses to 10-fold or greater amounts of LPS-LBP, yet does not block the same responses to TNFot or phorbol ester, diPS may be able to induce a LPS-specific inhibitory pathway. Thus, binding diPS to CD14 or another molecule might initiate a negative signal that counteracts the positive signal from LPS.
In keeping with the results of Wright et al. (8), we also observed that high concentrations (10 ng/ml) of LPS partinily overcame the inhibition of NF-r.B binding activity which resulted from blocking LPS binding to CD14 by mAb 60b. Since the uptake of LPS by the 60b-treated ceils was not above background (nonspeciiic) binding using our radiolabeled probe, small amounts of LPS may have been taken up by the cells via non-CD14 mechanisms and then interacted with another molecule or molecules in the signal pathway.
It seems likely that dLPS and LA-14-PP did not inhibit LPS uptake in our studies because the number of molecules of cell-surface CD14 greatly exceeded the number of molecules of ligand bound to the cells. By using LPS that was biosynthetically radiolabeled to high specific activity (30), we were able to measure much smaller amounts of LPS and diPS than had previously been possible in studies of LPS-cell interactions. The picogram amounts of cell-associated LPS that were measured in these experiments were near the dose threshold for cellular responses in this in vitro system. The LPS uptake was equivalent to 2,250-165,000 molecules per cell, well below the number of CD14 molecules on the calls (106 or more). The great excess of call-surface CD14 thus provides a likely explanation for the lack of inhibition of LPS-LBP uptake by dLPS-LBP. R~ently, Couturier et al. (42) reported binding of derivatized [3H]LPS to human monocytes in the presence of FCS at room temperature. Binding appeared to be dose-dependent, saturable, displaceable, and inhibitable by antibodies to CD14. Saturating amounts of LPS (~,1/zg added per million ceils) were much higher than the concentrations used in the present study (0.1-10 ng LPS per million cells), again suggesting that saturation of CD14 occurs at LPS concentrations far greater than the low concentrations used here.
The present results seem most consistent with a scenario in which CD14 binds LPS and LPS-LBP, accumulating LPS on the plasma membrane where the fully acylated lipid A moiety can then interact with other key molecules in the response cascade, dips may also interact with these molecules but, lacking the necessary structural information (acyloxyacyl groups), dips is unable to initiate the signal. The ability of diPS to inhibit responses to much larger amounts of LPS, despite the presence of a large excess of CD14 on the cells, suggests that the putative signaling molecules are much less abundant than CD14.
The ability of preincubation with dLPS to prevent cellular responses to much larger amounts of LPS reinforces the suggestion (18) (19) (20) that diPS, if generated in vivo, might blunt responses to LPS and provide an LPS-specific mechanism for controlling the inflammatory response. Our findings also suggest that dips, generated intracellularly, might play a role in the induction of tolerance to LPS. Finally, it is possible, as suggested by Kovach et al. (23) , that part-structures of lipid A or LPS that lack acyloxyacyl groups could be useful therapeutics for gram-negative bacterial sepsis. Our results provide support for all of these speculations and encourage further efforts to evaluate them experimentally.
